Takaisin Tulosta

Prevalence of visual disability in screening studies

Lisätietoa aiheesta
Glaucoma Working Group
28.3.2023

The prevalence of visual disability among screened populations may vary between 0.03% and 2.4% while some registry-based retrospective studies have reported clearly higher prevalence rates compared to cross-sectional screening studies (visual disability in both eyes in 15% within 15 years and 22% in 20 years, visual disability in one eye in 9% in 10 years and 54% in 20 years). The Finnish study reported that 1.5% of patients using glaucoma medications were registered in the Registry of Visual Disability (Vaajanen et al 2021). As not all patients using glaucoma medications have glaucomatous abnormalities, the percentage can be higher.

The 1980-2019 data of the Finnish Register of Visual Impairment were reported. The criteria for vision loss were based the World Health Organization definitions (mild, moderate, severe, near total blindness and blindness). By the end of 2019, the registry included data on 58 822 visually impaired patients. 5819 patients had glaucoma as the main diagnosis (61 % females). The data of reimbursed glaucoma medications were available in 1986-2019 by the Finnish Social Insurance Institution.

Primary open-angle glaucoma was the main diagnosis in 45% of cases, followed by exfoliative glaucoma (30%) and normal-tension glaucoma (7 %). The incidence of visual disability per 100 000 citizens increased from 2.3 to 3.4 during four decades (p=0.0026) and was related to the increase in the ≥ 85 -year age group, especially in females.

The mean age of males was 74 years and 76 years in females and increased 4 years in males and 7 years in females in 1980-2019. The years with disability decreased from 10 to 7 years in females and from 10 to 9 years in males.

The percentage of mild vision loss increased from 40% to 51% during the 40 years (p < 0.0001) with no differences between gender. The incidence of vision impairment per 10 000 treated glaucoma patients decreased from 32 to 21 during the four decades (p < 0.0001).

Authors' conclusions:

During 4 decades, the incidence of glaucoma induced visual disability increased due to a shift into to older age groups and higher percentage of mild vision loss which may reflect to improved glaucoma care.

Screening studies R1-R8,Retrospective and registry base studies R9-R19

Kirjallisuutta

  1. Fleming C, Whitlock E, Beil T ym. 2005;: «PMID: 20722130»PubMed
  2. Hirvelä H. Visual function and ocular disease in the elderly. Acta Universitatis Ouluensis Medica, D327, 1995, Oulu
  3. Jonasson F, Thordarson K. Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1994. Acta Ophthalmol 1987;182:40-3; PMID: 2837059
  4. Coffey M, Reidy A, Wormald R ym. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 1993;77:17-21 «PMID: 8435391»PubMed
  5. Dielemans I, Vingerling JR, Wolfs RC ym. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 1994;101:1851-5 «PMID: 7800368»PubMed
  6. Sommer A, Tielsch JM, Katz J ym. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5 «PMID: 1867550»PubMed
  7. Sommer A, Tielsch JM, Katz J ym. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 1991;325:1412-7 «PMID: 1922252»PubMed
  8. Quigley HA, Tielsch JM, Katz J ym. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. Am J Ophthalmol 1996;122:355-63 «PMID: 8794708»PubMed
  9. Ang GS, Eke T. Lifetime visual prognosis for patients with primary open-angle glaucoma. Eye (Lond) 2007;21:604-8 «PMID: 16485015»PubMed
  10. Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol 2013;156:724-30 «PMID: 23932216»PubMed
  11. Peters D, Bengtsson B, Heijl A. Factors associated with lifetime risk of open-angle glaucoma blindness. Acta Ophthalmol 2014;92:421-5 «PMID: 23837818»PubMed
  12. Forsman E, Kivelä T, Vesti E. Lifetime visual disability in open-angle glaucoma and ocular hypertension. J Glaucoma 2007;16:313-319; PMID:17438426
  13. Hattenhauer MG, Johnson DH, Ing HH ym. The probability of blindness from open-angle glaucoma. Ophthalmology 1998;105:2099-104 «PMID: 9818612»PubMed
  14. King AJ, Reddy A, Thompson JR ym. The rates of blindness and of partial sight registration in glaucoma patients. Eye (Lond) 2000;14 ( Pt 4):613-9 «PMID: 11040909»PubMed
  15. Blomdahl S, Calissendorff BM, Tengroth B ym. Blindness in glaucoma patients. Acta Ophthalmol Scand 1997;75:589-91 «PMID: 9469562»PubMed
  16. Chen PP. Blindness in patients with treated open-angle glaucoma. Ophthalmology 2003;110:726-33 «PMID: 12689894»PubMed
  17. Ederer F, Gaasterland DA, Dally LG ym. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64 «PMID: 15051195»PubMed
  18. Kwon YH, Kim CS, Zimmerman MB ym. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol 2001;132:47-56 «PMID: 11438053»PubMed
  19. Vaajanen A, Purola P, Ojamo M ym. Changes in incidence and severity of visual impairment due to glaucoma during 40 years - a register-based study in Finland. Acta Ophthalmol 2021;: «PMID: 34595821»PubMed